Conservative treatment of endometrial cancer and atypical hyperplasia;Traitement conservateur du cancer et des hyperplasies atypiques de l'endomètre

Gynecologie Obstetrique et Fertilite

Volumn 32, Issue 5, 2004, Pages 433-441

  Yazbeck, C ^a   Dhainaut, C ^a   Thoury, A ^a   Driguez, P ^a   Madelenat, P ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Endometrial cancer; Fertility; Progestins

Indexed keywords

MEGESTROL ACETATE; NORETHISTERONE; PROGESTERONE DERIVATIVE;

ALTERNATIVE MEDICINE; CANCER RISK; CONSERVATIVE TREATMENT; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FERTILITY; HEALTH SURVEY; HUMAN; HYSTERECTOMY; MEDICAL PRACTICE; MOLECULAR RECOGNITION; PELVIS CANCER; PREGNANCY; PROBABILITY; REVIEW;

EID: 2942662043     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2004.01.017     Document Type: Article

References (43)

1. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001 Jun;15(3):341-54.
2. Farquhar CM, Lethaby A, Sowter M, Verry J, Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol 1999 Sep; 181(3): 525-9.
3. Leeson S. Guidelines for endometrial carcinoma. British Gynaecological Cancer Society, BGCS; 2002 Sep.
4. Benedet JL, Bender H, Jones 3rd H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynaecol Obstet 2000;70 209-62 FIGO Committee on Gynecologic Oncology.
5. Skov BG, Broholm H, Engel U, Franzmann MB, Nielsen AL, Lauritzen AF, Skov T. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int J Gynecol Pathol 1997 Jan;16(1):33-7.
6. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982 Jun 15;49(12):2547-59.
7. Chen SS, Lee L. Retroperitoneal lymph node metastases in Stage I carcinoma of the endometrium: correlation with risk factors. Gynecol Oncol 1983 Dec;16(3):319-25.
8. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG Miller A, Blessing JA. Surgical staging in endometrial cancer: clinicalpathologic findings of a prospective study. Obstet Gynecol 1984 Jun;63(6):825-32.
9. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE Heller PB. Surgical pathologic spread patterns of endometrial cancer. Cancer 1987 Oct 15;60(8 Suppl):2035-41 A Gynecologic Oncology Group Study.
10. Straughn Jr JM, Huh WK, Kelly FJ, Leath 3rd CA, Kleinberg MJ, Hyde Jr J, et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 2002 Feb;84(2):194-200.
11. Sardi J, Anchezar Henry JP, Paniceres G, Gomez Rueda N, Vighi S. Primary hormonal treatment for early endometrial carcinoma. Eur J Gynaecol Oncol 1998;19(6):565-8.
12. Plante M. Fertility preservation in the management of gynecologic cancers. Curr Opin Oncol 2000 Sep;12(5):497-507.
13. Kempson RL, Pokorny GE. Adenocarcinoma of the endometrium in women aged forty and younger. Cancer 1968 Apr;21(4):650-62.
14. O'Neill RT. Pregnancy following hormonal therapy for adenocarcinoma of the endometrium. Am J Obstet Gynecol 1970 Sep 15;108(2):318-21.
15. Fechner RE, Kaufman RH. Endometrial adenocarcinoma in Stein-Leventhal syndrome. Cancer 1974 Aug;34(2):444-52.
16. Eddy WA. Endometrial carcinoma in Stein-Leventhal syndrome treated with hydroxyprogesterone caproate. Am J Obstet Gynecol 1978 Jul 1;131(5):581-2.
17. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 1985 Jul 15;56(2):403-12.
18. Thornton JG, Brown LA, Wells M, Scott JS. Primary treatment of endometrial cancer with progestagen alone. Lancet 1985 Jul 27;2(8448):207-8.
19. Farhi DC, Nosanchuk J, Silverberg SG. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 1986 Dec;68(6):741-5.
20. Lai CH, Hsueh S, Chao AS, Soong YK. Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma. Br J Obstet Gynaecol 1994 Jun;101(6):547-9.
21. Kimmig R, Strowitzki T, Muller-Hocker J, Kurzl R, Korell M, Hepp H. Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 1995 Aug;58(2):255-7.
22. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997 Sep;90(3):434-40.
23. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997 Jan 15;79(2):320-7.
24. Schammel DP, Mittal KR, Kaplan K, Deligdisch L, Tavassoli FA. Endometrial adenocarcinoma associated with intrauterine pregnancy. A report of five cases and a review of the literature. Int J Gynecol Pathol 1998 Oct;17(4):327-35.
25. Shibahara H, Shigeta M, Toji H, Wakimoto E, Adachi S, Ogasawara T, et al. Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection. Hum Reprod 1999 Jul;14(7):1908-11.
26. Kowalczyk CL, Malone Jr J, Peterson EP, Jacques SM, Leach RE. Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report. J Reprod Med 1999 Jan;44(1):57-60.
27. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations. Eur J Gynaecol Oncol 2001;22(3):217-20.
28. Pinto AB, Gopal M, Herzog TJ, Pfeifer JD, Williams DB. Successful in vitro fertilization pregnancy after conservative management of endometrial cancer. Fertil Steril 2001 Oct;76(4):826-9.
29. Wang CB, Wang CJ, Huang HJ, Hsueh S, Chou HH, Soong YK, Lai CH. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 2002 Apr 15;94(8):2192-8.
30. Yazbeck C, Poncelet C, Crequat J, Madelenat P. Intérêt de l'échographie endovaginale préopératoire dans l'évaluation de l'infiltration myométriale des adénocarcinomes de l'endomètre. Gynecol Obstet Fertil 2003;31(12):1024-9.
31. Kung FT, Chen WJ, Chou HH, Ko SF, Chang SY. Conservative management of early endometrial adenocarcinoma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy. Hum Reprod 1997 Aug;12(8):1649-53.
32. Ueki M, Inoki C, Ueda M, Tsutsumi A, Nakazato M, Daikuzono N. Experimental and clinical studies on balloon laserthermia using Nd: YAG laser for uterine endometrial cancer. Lasers Surg Med 1996;18(2):178-86.
33. Agorastos T, Bontis J, Vakiani A, Vavilis D, Constantinidis T. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data. Gynecol Oncol 1997 Apr;65(1):102-14.
34. Grimbizis G, Tsalikis T, Tzioufa V, Kasapis M, Mantalenakis S. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study. Hum Reprod 1999 Feb;14(2):479-84.
35. Lopes P. Prise en charge de la femme ménopausée à risque. Communication orale aux XVIIe journées de techniques avancées en gynécologie-obstétrique. Punta Cana: JTA; 2002.
36. Perez-Medina T, Bajo J, Folgueira G, Haya J, Ortega P. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up. Gynecol Oncol 1999 May;73(2):299-304.
37. Mitsushita J, Toki T, Kato K, Fujii S, Konishi I. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecol Oncol 2000 Oct;79(1):129-32.
38. Muechler EK, Bonfiglio T, Choate J, Huang KE. Pregnancy induced with menotropins in a woman with polycystic ovaries, endometrial hyperplasia, and adenocarcinoma. Fertil Steril 1986 Nov;46(5):973-5.
39. Paulson RJ, Sauer MV, Lobo RA. Pregnancy after in vitro fertilization in a patient with stage I endometrial carcinoma treated with progestins. Fertil Steril 1990 Oct;54(4):735-6.
40. Niwa K, Yokoyama Y, Tanaka T, Murase T, Morishita S, Itoh M, et al. Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Arch Gynecol Obstet 1994;255(2):91-4.
41. Zanetta G, Gabreiele A, Losa G, Cappelini A, Mangioni C. Conservative management of endometrial carcinoma with prolonged preservation of the uterus in a young patient. Int J Gynecol Cancer 1997;7:332-4.
42. Lee KR, Scully RE. Complex endometrial hyperplasia and carcinoma in adolescents and young women 15 to 20 years of age. A report of 10 cases. Int J Gynecol Pathol 1989;8(3):201-13.
43. Ojomo EO, Ezimokhai M, Reale FR, Nwabineli NJ. Recurrent postpartum haemorrhage caused by endometrial carcinoma co-existing with endometrioid carcinoma of the ovary in a full term pregnancy. Br J Obstet Gynaecol 1993 May;100(5):489-91.